"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors

Exp Dermatol. 2023 Dec;32(12):2187-2188. doi: 10.1111/exd.14731. Epub 2022 Dec 26.
No abstract available

Keywords: IL17 inhibitors; Il23 inhibitors; PASI; biologics; psoriasis; superresponders.

Publication types

  • Letter
  • Comment

MeSH terms

  • Biological Products*
  • Humans
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Biological Products